Waldencast PLC (WALDW) — 6-K Filings

6-K Filings (26)

• 6-K Filing — Dec 19, 2025
• 6-K Filing — Nov 24, 2025
• Waldencast Sells Japan Obagi Trademark, Refinances Debt — Nov 14, 2025 Risk: medium
  On November 14, 2025, Waldencast plc announced the sale of its rights to the "Obagi" trademark in Japan. Additionally, the company entered into a new credit fac
• Waldencast's Obagi Gets FDA Nod for New Injectable — Sep 10, 2025 Risk: low
  On September 10, 2025, Waldencast plc announced that its Obagi brand received FDA approval for its new product, Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid
• Waldencast plc Reports H1 2025 Progress and Transformation Initiatives — Aug 18, 2025 Risk: low
  On August 18, 2025, Waldencast plc announced strong progress on its business priorities for the first half of 2025 and outlined initiatives to drive transformat
• Waldencast plc Acquires Novaestiq Corp. — Jul 23, 2025 Risk: medium
  On July 22, 2025, Waldencast plc acquired Novaestiq Corp. through its subsidiary Novaestiq Holding LLC via a common stock purchase agreement. Waldencast plc, fo
• Waldencast plc Reports Q1 2025 Financial Results — May 14, 2025 Risk: low
  Waldencast plc announced its Q1 2025 financial results on May 13, 2025, via an updated corporate presentation. The filing covers the period ending March 31, 202
• Waldencast plc Reports Q1 2025 Financial Results — May 13, 2025 Risk: low
  Waldencast plc announced its Q1 2025 financial results on May 13, 2025, for the period ending March 31, 2025. The company, formerly known as Waldencast Acquisit
• Waldencast plc Reports Q4 2024 Financial Results — Mar 19, 2025 Risk: low
  On March 19, 2025, Waldencast plc announced its Q4 2024 financial results via an updated corporate presentation. The company, formerly known as Waldencast Acqui
• Waldencast plc Reports Q4 and FY 2024 Financial Results — Mar 18, 2025 Risk: low
  On March 18, 2025, Waldencast plc announced its financial results for the fourth quarter and full year ended December 31, 2024. The company, formerly known as W
• Waldencast plc Reports Q3 2024 Financial Results — Nov 21, 2024 Risk: low
  Waldencast plc announced its Q3 2024 financial results on November 21, 2024, via an updated corporate presentation. The company, formerly known as Waldencast Ac
• Waldencast plc Sets Q3 Earnings Release Date — Nov 13, 2024 Risk: low
  Waldencast plc announced on November 12, 2024, that it will release its third quarter financial results for the period ending September 30, 2024, before market
• Waldencast plc Files Amended Articles of Association — Oct 30, 2024 Risk: low
  Waldencast plc filed an amended Articles of Association on October 30, 2024. This filing, a Form 6-K, is a report of a foreign private issuer and does not conta
• Waldencast plc Sets Annual General Meeting for November 15 — Oct 7, 2024 Risk: low
  Waldencast plc announced on October 7, 2024, that it will hold its Annual General Meeting on November 15, 2024. The meeting will include the election of directo
• Waldencast plc Reports Q2 2024 Financial Results — Aug 28, 2024 Risk: low
  On August 28, 2024, Waldencast plc announced its financial results for the second quarter of 2024. The company, formerly known as Waldencast Acquisition Corp. u
• Waldencast plc Files 6-K with H1 2024 Financials — Aug 27, 2024 Risk: low
  Waldencast plc filed a Form 6-K on August 27, 2024, reporting its six-month interim financial statements for the period ended June 30, 2024. The company, previo
• Waldencast plc to Announce Q2 2024 Financial Results — Aug 21, 2024 Risk: low
  Waldencast plc announced on August 21, 2024, that it will report its financial results for the second quarter of 2024. The company, formerly known as Waldencast
• Waldencast plc Sets Q2 2024 Earnings Release Date — Jun 27, 2024 Risk: low
  Waldencast plc announced on June 27, 2024, that it will release its financial results for the second quarter of 2024 after market close on July 25, 2024. The co
• Waldencast plc Reports Q1 2024 Financial Results — May 21, 2024 Risk: low
  On May 21, 2024, Waldencast plc announced its Q1 2024 financial results. The company, previously known as Waldencast Acquisition Corp. until January 12, 2021, i
• Waldencast plc to Announce Q1 2024 Earnings on May 21 — May 13, 2024 Risk: low
  Waldencast plc announced on May 13, 2024, that it will release its first quarter 2024 financial results before the market opens on May 21, 2024. The company wil
• Waldencast plc Reports FY2022 Financial Results — Apr 30, 2024 Risk: low
  On April 30, 2024, Waldencast plc announced its fiscal year 2022 financial results. The company, previously known as Waldencast Acquisition Corp. until January
• Waldencast plc Regains Nasdaq Compliance — Mar 25, 2024 Risk: medium
  Waldencast plc announced on March 21, 2024, that it has regained compliance with Nasdaq's minimum bid price requirement. The company had previously received a d
• Waldencast plc Files 6-K with Interim Financials — Mar 21, 2024 Risk: low
  Waldencast plc filed a Form 6-K on March 21, 2024, to furnish interim financial statements for the period ending March 31, 2022. The company, previously known a
• Waldencast Secures Positive Nasdaq Listing Determination — Feb 26, 2024 Risk: low
  Waldencast plc, a foreign private issuer, received a positive listing determination from Nasdaq on February 22, 2024. This 6-K filing, submitted on February 26,
• Waldencast Appoints L'Oréal Veteran Manuel Manfredi as New CFO — Jan 31, 2024
  Waldencast plc announced on January 31, 2024, the appointment of Manuel Manfredi, 48, as its new Chief Financial Officer, effective April 1, 2024. Mr. Manfredi
• Waldencast Gets New Nasdaq Non-Compliance Notice for Missed Filing — Jan 9, 2024
  Waldencast plc, a beauty and wellness company, received an additional notice of non-compliance from Nasdaq on January 3, 2024, for failing to file its interim f

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX